Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OnPoint Hip is a privately held medical technology company within the OnPoint AR-AI group focused on augmented reality and artificial intelligence-guided solutions for orthopedic surgery, particularly hip replacement. The company is part of a family of OnPoint entities developing see-through optical head-mounted display systems that superimpose virtual surgical guides and implants onto the surgeon’s field of view. Its technology is positioned as an open surgical guidance platform intended to improve intraoperative accuracy, workflow efficiency, and outcomes in manual and robotic procedures. Public information on OnPoint Hip specifically is limited, but company materials consistently describe it as one of the OnPoint businesses targeting hip arthroplasty applications within a broader AR-guided surgical portfolio. The broader OnPoint group has highlighted a substantial patent estate and commercialization progress through FDA-cleared spine products, indicating that the hip business is associated with an active medtech platform rather than a therapeutics pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OnPoint Hip.